drugset / Trial / NCT01909466
Safety and Tolerability Study of Aripiprazole IM Depot in Adult Subjects With Schizophrenia
Phase 1
Completed
141 enrolled
Otsuka Pharmaceutical Development & Commercialization, Inc.
H. Lundbeck A/S · collab
RandomizedParallel-groupOpen-labelTreatment
Summary
To determine the safety and tolerability of multiple-dose administrations of aripiprazole intramuscular (IM) depot in the deltoid muscle in adult subjects with schizophrenia
Timeline
- Start
- 2013-07
- Primary completion
- 2014-03
- Completion
- 2014-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Aripiprazole | Other / unclassified | 400 mg | Intramuscular |